CALTON & ASSOCIATES, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
CALTON & ASSOCIATES, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$113,848
-3.0%
22,907
-3.6%
0.05%
-1.9%
Q1 2023$117,382
+14.4%
23,761
+45.6%
0.05%
+35.0%
Q4 2022$102,616
-16.6%
16,314
+42.3%
0.04%
-42.9%
Q3 2022$123,000
-37.6%
11,468
-33.9%
0.07%
-35.8%
Q2 2022$197,000
+18.7%
17,352
-5.3%
0.11%
+122.4%
Q1 2022$166,000
-32.2%
18,329
+92.0%
0.05%
-9.3%
Q3 2021$245,000
+14.5%
9,546
+57.3%
0.05%
+28.6%
Q1 2021$214,0006,0670.04%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders